OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
22
Results
Show all
Save search
Copy query
Show results for
Unknown
(22)
Publication Date
Release Date
2023
(7)
2025
(4)
2022
(4)
2021
(3)
2026
(2)
2024
(2)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
A systematic review and network meta-analysis on the effectiveness of exercise-based interventions for reducing the injury incidence in youth team-sport players. Part 1: an analysis by classical training components.
Not available
S-EPMC11445890
|
biostudies-literature
Cite
Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial.
Not available
S-EPMC7876892
|
biostudies-literature
Cite
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial.
Not available
S-EPMC8158477
|
biostudies-literature
Cite
Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia.
Not available
S-EPMC11208994
|
biostudies-literature
Cite
The transcriptomic landscape of elderly acute myeloid leukemia identifies
B7H3
and
BANP
as a favorable signature in high-risk patients.
Not available
S-EPMC9729799
|
biostudies-literature
Cite
Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAF<sup>V600</sup>-mutant melanoma in Spain: the BECARE (GEM-2002) trial.
Not available
S-EPMC11897558
|
biostudies-literature
Cite
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
Not available
S-EPMC10182047
|
biostudies-literature
Cite
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia.
Not available
S-EPMC9811200
|
biostudies-literature
Cite
Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational study.
Not available
S-EPMC10470432
|
biostudies-literature
Cite
Quizartinib for Newly Diagnosed <i>FLT3</i>-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.
Not available
S-EPMC12736402
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets